Sign in

CIK 0001867096 · Large accelerated filer

Xeris Biopharma Holdings, Inc.

Sign in to watch
Ticker
XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
871082097
Phone
844-445-5704
Business address
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
  1. 4 Grant or award See Remarks acquired 450,000 shares (grant or award)
  2. 4 Grant or award See Remarks acquired 750,000 shares (grant or award)
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. SC 13G Stake Amended Statement of Ownership
  7. 8-K Event Results of operations
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. 8-K Event Regulation FD disclosure
  17. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  18. 8-K Event Material agreement · Unregistered share sale · Other events
  19. 4 Insider Changes in Ownership
  20. 10-Q Report Quarterly Report

Page 11 of 18 · 346 filings